Objective: To determine the incidence and risk factors of chronic critical illness after severe blunt trauma. Design: Prospective observational cohort study (NCT01810328). Setting: Two-level one trauma centers in the United States. Patients: One hundred thirty-five adult blunt trauma patients with hemorrhagic shock who survived beyond 48 hours after injury. Interventions: None. Measurements and Main Results: Chronic critical illness was defined as an ICU stay lasting 14 days or more with evidence of persistent organ dysfunction. Three subjects (2%) died within the first 7 days, 107 (79%) exhibited rapid recovery and 25 (19%) progressed to chronic critical illness. Patients who developed chronic critical illness were older (55 vs 44-year-old; p = 0.01), had more severe shock (base deficit, -9.2 vs -5.5; p = 0.005), greater organ failure severity (Denver multiple organ failure score, 3.5 +/- 2.4 vs 0.8 +/- 1.1; p
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2wL3EWw
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Ravulizumab (ravulizumab-cwvz; ULTOMIRIS™), a humanized monoclonal antibody, is a complement C5 inhibitor developed by Alexion Ph...
-
http://bit.ly/2TO0eLw
-
Abstract Purpose To analyze the differences in outcomes between primary and secondary definitive osteosynthesis for fractures of the lower...
-
Abstract Objective Long-acting synthetic somatostatin analogues (SSA) are an essential part of the treatment of neuroendocrine neoplasms...
-
http://sfaki.blogspot.com/2017/06/monoclonal-antibodies-against-il-5-or.html Alexandros Sfakianakis Anapafseos 5 . Agios Nikolaos Crete.Gree...
-
Abstract Background Depression following the diagnosis of breast cancer has been well documented, and occurs in as many as 40% of women....
-
CHARLOTTE HALL, Md. — EMS job seekers are given specific reasons to not apply for a position in a job posting for paramedics, EMTs and dispa...
-
Academic Radiology from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2t1H331
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου